𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Design of bifunctional radiopharmaceutical for the development of 99mTc complexes for myocardial imaging agents

✍ Scribed by Hosotani, Takeo; Yokoyama, Akira; Arano, Yasushi; Horiuchi, Kazuko; Saji, Hideo; Torizuka, Kanji

Book ID
123579585
Publisher
Elsevier Science
Year
1986
Weight
674 KB
Volume
13
Category
Article
ISSN
0883-2897

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

99mTc-labelling of leucocytes with99mTc-
99mTc-labelling of leucocytes with99mTc-DPO: a complex developed for myocardial imaging
✍ G. Endert; U. Franke; P. Kleinert πŸ“‚ Article πŸ“… 1989 πŸ› Springer 🌐 English βš– 414 KB

The lipophilic 99mTc-DPO complex, developed as a myocardial imaging radiopharmaceutical, was used to label leucocytes. After an incubation of 0.1 ml 99mTc-DPO (8 micrograms DMPE\*2HCl) with mixed leucocytes in plasma, the labelling efficiency was over 70%. During incubation in 5 ml plasma, a loss of

Search for 99mTc labeled DTS bifunctiona
Search for 99mTc labeled DTS bifunctional radiopharmaceutical: Role of functional groups in myocardial accumulation
✍ Takeo Hosotani; Akira Yokoyama; Yasushi Arano; Kazuko Horiuchi; Hideo Saji; Kanj πŸ“‚ Article πŸ“… 1986 πŸ› Elsevier Science βš– 651 KB

Development of 99mTc-bifunctional radiopharmaceutical (BR) is attracting the interest of various research groups. In the present paper, various molecules containing a neutral 99mTc-dithiosemicarbazone (DTS) structure as the technetium chelating site, along with various functional groups (amino, carb

The influence of reducing agents on the
The influence of reducing agents on the composition of99Tc-complexes: Implications for99mTc-radiopharmaceutical preparation
✍ John Baldas; John Bonnyman; Peter M. Pojer; Geoffrey A. Williams πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 256 KB

The use of formamidine sulphinic acid as a reducing agent in the presence of technetium-99-pertechnetate and diethyldithiocarbamate ligand has been shown to yield a complex containing a Tc = CO bond. The carbon monoxide present in this complex originates from the reducing agent itself. Evidence is p